| __timestamp | PTC Therapeutics, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 5496000 |
| Thursday, January 1, 2015 | 82080000 | 9786000 |
| Friday, January 1, 2016 | 97130000 | 6792000 |
| Sunday, January 1, 2017 | 121271000 | 7313000 |
| Monday, January 1, 2018 | 153548000 | 8382000 |
| Tuesday, January 1, 2019 | 202541000 | 10803000 |
| Wednesday, January 1, 2020 | 245164000 | 12944000 |
| Friday, January 1, 2021 | 285773000 | 21967000 |
| Saturday, January 1, 2022 | 325998000 | 32810000 |
| Sunday, January 1, 2023 | 332540000 | 46542000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, operational efficiency is paramount. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of PTC Therapeutics, Inc. and Xenon Pharmaceuticals Inc. over the past decade. From 2014 to 2023, PTC Therapeutics has seen a staggering increase in SG&A expenses, growing by over 640%, from approximately $44.8 million to $332.5 million. In contrast, Xenon Pharmaceuticals, while also experiencing growth, has maintained a more conservative increase of around 747%, from $5.5 million to $46.5 million. This stark difference highlights PTC's aggressive expansion strategy compared to Xenon's more measured approach. As the biotech industry continues to evolve, understanding these financial dynamics offers valuable insights into each company's strategic priorities and operational focus.
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Xenon Pharmaceuticals Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Biogen Inc. and Xenon Pharmaceuticals Inc.
Incyte Corporation or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Incyte Corporation vs PTC Therapeutics, Inc. Trends and Insights
Bio-Techne Corporation or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Opthea Limited and PTC Therapeutics, Inc.
PTC Therapeutics, Inc. vs Perrigo Company plc: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or MannKind Corporation
Breaking Down SG&A Expenses: Xenon Pharmaceuticals Inc. vs ImmunityBio, Inc.